Semaglutide Patent Expiry: 5 Ways India’s Obesity Drug Market Is About to Change
Introduction The semaglutide patent has expired in India on March 20. Semaglutide is a GLP-1 receptor agonist widely used for […]
Introduction The semaglutide patent has expired in India on March 20. Semaglutide is a GLP-1 receptor agonist widely used for […]